Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc., trading under the ticker PWUP, is a blank check company formed to pursue a business combination in the biopharma and life sciences sector. The company filed a 10-Q with the SEC on August 11, 2022, reflecting its status as an active SPAC in its search phase at that time. Aspire Biopharma Holdings completed its initial public offering in 2022, positioning itself to target opportunities across the biopharmaceutical industry at a period of elevated SPAC activity in healthcare. For complete filing history, deal status, sponsor details, and real-time updates on PWUP and hundreds of other SPACs, sign up for full access at SpacDesk.